Risk Stratification in Patients with Coronary Artery Disease: A Practical Walkthrough in the Landscape of Prognostic

Sergio Buccheri1,2, Paolo D'Arrigo1, Gabriele Franchina1

  • 1CAST, AOU. Policlinico-Vittorio Emanuele, University of Catania Catania, Italy.

Insights

Personalized medicine improves coronary artery disease (CAD) outcomes by considering individual factors. This review guides clinicians on using risk scoring systems for better prognostic stratification in CAD patients.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Public Health

Background:

  • Coronary artery disease (CAD) remains a leading global cause of death despite advances in prevention and treatment.
  • Individual patient factors significantly influence CAD outcomes, necessitating personalized approaches over generalized strategies.
  • The proliferation of CAD risk scoring systems has created complexity in clinical decision-making.

Purpose of the Study:

  • To review established risk models for patients with diagnosed coronary artery disease (CAD).
  • To offer practical guidance on the application of prognostic risk stratification tools.
  • To address the uncertainty surrounding the adoption of predictive models in clinical practice.

Main Methods:

  • Literature review of accepted risk models for coronary artery disease (CAD).
  • Analysis of the utility and application of various prognostic risk stratification tools.
  • Synthesis of information to provide clinical decision-making guidance.

Main Results:

  • Identified and summarized the most accepted risk models for CAD prognostic stratification.
  • Highlighted the importance of personalized medicine in managing CAD.
  • Provided a framework for understanding and applying risk models in clinical settings.

Conclusions:

  • Risk stratification models are crucial for personalized CAD management.
  • Clinicians need clear guidance to effectively utilize predictive tools for better patient outcomes.
  • Adopting appropriate risk models can enhance the precision of CAD treatment strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373